Table 3.
Time points | Groups (HHS Median [percentile25-percentile75]) | Overall | |||
---|---|---|---|---|---|
Stage II | Stage III | Type C1 | Type C2 | ||
Pre-op | 59 (56–61) | 53 (46–56) | 57 (52–61) | 61 (55–63) | 59 (55–61) |
24 ms | 86 (83–90) ** | 79 (68–84) **, ¶¶ | 86 (82–90) ** | 68 (61–83) ¶¶ | 85 (79–90) ** |
60 ms | 89 (88–91) ** | 90 (78–91) ** | 90 (87–91) ** | 82 (65–88) ¶ | 89 (86–91) ** |
96 ms | 94 (90–96) ** | 92 (90–95) ** | 94 (91–96) ** | 89 (70–94) * | 94 (91–96) ** |
**: Significant difference compared to pre-op HHS score in each group (P < 0.01); *: Significant difference compared to pre-op HHS score in each group (P < 0.05)
¶: Significant difference compared to stage II / Type C1 at the same time point (P < 0.05)
¶¶: Significant difference compared to stage II / Type C1 at the same time point (P < 0.01)